Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818737 · ClinicalTrials.gov registry record · Phase 3
Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)
A Phase 3 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 3
- Development phase
- 475
- Enrollment target
NCT03818737 is a Phase 3 study that has completed, run by Emory University. The registered enrollment target is 475 participants.
The verdict
NCT03818737, a Phase 3 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 475 participants
- Enrollment target
Study Summary
The study is a multicenter trial conducted to compare the effectiveness of an injection of a corticosteroid control to mesenchymal stem cell (MSC) preparations from autologous bone marrow concentrate (BMAC), adipose derived stem cells in the form of Stromal Vascular Fraction (SVF), and third-party human mesenchymal stem cells manufactured from umbilical cord tissue (UCT) for the treatment of unilateral Knee Osteoarthritis (OA). The study will be conducted in 4 sites in the United States, and a total of 480 participants will be enrolled in this study.
Interventions
- DRUG Corticosteroid injection
- BIOLOGICAL Bone Marrow Derived MSCs
- BIOLOGICAL Adipose-derived MSCs
- BIOLOGICAL Umbilical Cord Tissue (UCT) MSCs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 475 participants |
| Start Date | 2019-03-28 |
| Est. Completion | 2022-05-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03818737
The ClinicalTrials.gov registry entry for NCT03818737 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 475 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Corticosteroid injection is the first listed.
NCT03818737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03818737 about?
NCT03818737 is a clinical study titled "Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)". The study is a multicenter trial conducted to compare the effectiveness of an injection of a corticosteroid control to mesenchymal stem cell (MSC) preparations from autologous bone marrow concentrate (BMAC), adipose derived stem cells in the form of Stromal Vascular Fraction (SVF), and third-party h...
What is the current status of trial NCT03818737?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 475 participants. The study started on 2019-03-28. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT03818737?
The interventions under investigation include: Corticosteroid injection (DRUG), Bone Marrow Derived MSCs (BIOLOGICAL), Adipose-derived MSCs (BIOLOGICAL), Umbilical Cord Tissue (UCT) MSCs (BIOLOGICAL).
Who is sponsoring clinical trial NCT03818737?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.